These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26284773)

  • 21. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
    Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
    Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
    Yabuuchi H; Matsuo Y; Abe K; Baba S; Sunami S; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Nagao M; Okamoto T; Nakamura K; Yamamoto H; Sasaki M; Honda H
    Clin Radiol; 2015 Nov; 70(11):1289-98. PubMed ID: 26272529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
    Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
    Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of [
    Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
    Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of Interobserver Agreement and Diagnostic Accuracy for IASLC/ITMIG Thymic Epithelial Tumor Staging Among Co-registered FDG-PET/MRI, Whole-body MRI, Integrated FDG-PET/CT, and Conventional Imaging Examination with and without Contrast Media Administrations.
    Ohno Y; Kishida Y; Seki S; Koyama H; Yui M; Aoyagi K; Yoshikawa T
    Acad Radiol; 2022 Mar; 29 Suppl 3():S122-S131. PubMed ID: 29395795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.
    Kaira K; Murakami H; Miura S; Kaira R; Akamatsu H; Kimura M; Ono A; Tsuya A; Nakamura Y; Naito T; Takahashi T; Endo M; Yamamoto N
    Ann Nucl Med; 2011 May; 25(4):247-53. PubMed ID: 21174178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
    Liu Y
    Nucl Med Commun; 2011 Jul; 32(7):554-62. PubMed ID: 21403583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reply to Bertolaccini et al.
    Fukumoto K; Yokoi K
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):188-9. PubMed ID: 23341042
    [No Abstract]   [Full Text] [Related]  

  • 30. 18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
    Thomas A; Mena E; Kurdziel K; Venzon D; Khozin S; Berman AW; Choyke P; Szabo E; Rajan A; Giaccone G
    Clin Cancer Res; 2013 Mar; 19(6):1487-93. PubMed ID: 23382114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
    Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
    Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
    J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?
    Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Agarwal JP; Prabhash K; Noronha V; Joshi A; Kumar R; Rangarajan V
    Indian J Cancer; 2016; 53(2):270-273. PubMed ID: 28071625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
    Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors.
    Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W
    Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.
    Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA
    J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
    Moon SH; Kim HS; Cho YS; Sun JM; Ahn JS; Park K; Kim BT; Ahn MJ; Lee KH
    Lung Cancer; 2016 Oct; 100():24-29. PubMed ID: 27597277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.
    Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R
    Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.